绿叶制药：南京信安及宁波信达同意向南京绿叶合共注资2.85亿元

Group 1 - The core announcement is that Green Leaf Pharmaceutical has entered into a capital injection agreement with several entities, which will result in a total investment of RMB 285 million [1] - Following the completion of the capital injection, the ownership structure of Nanjing Green Leaf will be as follows: Shenzhen Green Leaf will hold 70.01%, Nanjing Xinshi 23.34%, Nanjing Xinan 4.32%, and Ningbo Xinda 2.33% [1]